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OBJECTIVES The purpose of this study was to validate electromechanical viability parameters with
combined myocardial perfusion and metabolic imaging and echocardiography.
BACKGROUND The NOGA System is a catheter-based, non-fluoroscopic, three-dimensional endocardial
mapping system. This unique technique allows accurate simultaneous assessment of both local
electrical activity and regional contractility.
METHODS The results of NOGA, myocardial single-photon emission computed tomography (SPECT),
positron emission tomography, and echocardiography in 51 patients with coronary artery
disease and a pathologic SPECT study were transcribed in a nine-segment bull’s-eye
projection and compared.
RESULTS The local shortening of normally contracting segments, as shown by echocardiography, was
9.2  5.1%, which decreased to 6.6  5.0% and 4.1  5.2% in hypokinetic and akinetic
segments. The highest unipolar voltage (11.2  5.0 mV) and local shortening (8.2  5.0%)
characterized normally perfused segments. Fixed perfusion defects with normal or limited
18-fluoro-2-deoxy-D-glucose uptake indicating viability had a significantly higher unipolar
voltage than did scar tissue (7.25  2.7 vs. 5.0  3.1 mV, p  0.029).
CONCLUSIONS Electromechanical parameters sufficiently defined the viability state of the myocardium and
showed good concordance with the findings by nuclear perfusion and metabolism imaging
and echocardiography. The NOGA technique provides all the relevant information imme-
diately after coronary angiography and enables the physician to proceed with therapy in the
same setting. (J Am Coll Cardiol 2002;40:1067–74) © 2002 by the American College of
Cardiology Foundation
Patients with reduced left ventricular (LV) performance due
to viable but hibernating myocardium will show a substan-
tial survival benefit after revascularization (1). Nuclear
perfusion and metabolism imaging techniques are the
golden standard for predicting functional recovery after
revascularization (2–7), but they cannot be performed at the
time of coronary angiography, which may lead to an
inherent time delay between the diagnostic angiographic
procedure and the interventional or surgical therapy.
See page 1075
The NOGA three-dimensional electromechanical endo-
cardial mapping system, a non-fluoroscopic method that
allows simultaneous assessment of both local electrical
activity and regional contractility, offers this in-laboratory
diagnostic potential. The system has been validated in
animal models (8–11) and in a preliminary clinical study
comparing the electromechanical features of infarcted
areas with those of regions remote from the area of
infarction (12).
The hypothesis that viable myocardium can be distinctly
characterized by an electromechanical mismatch (or disso-
ciation), defined as preserved electrical activity with de-
creased mechanical activity, was recently proven in a hiber-
nation model (13). A comparison in human patients of
NOGA results with thallium myocardial scintigraphy
showed good concordance with respect to the identification
of viable and non-viable myocardium (14).
The purpose of this study was to validate NOGA
electromechanical viability parameters with combined myo-
cardial perfusion and metabolism imaging by comparing the
NOGA results with the results of technetium-99m (99mTc)
tetrofosmin single-photon emission computed tomography
(SPECT), metabolic imaging with 18-fluoro-2-deoxy-D-
glucose (FDG) positron emission tomography (PET), and
echocardiography.
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METHODS
Patient population and selection. The study population
consisted of 51 consecutive patients with proven coronary
artery disease (35 men and 16 women; mean age 61  9.7
years). Forty-two patients had a previous Q-wave MI (n 
18) or non–Q-wave myocardial infarction (n  24). The
mean ejection fraction was 51  14%. In all patients,
echocardiography and nuclear imaging were performed
within eight days of the NOGA procedure. Thirty-one
patients with a fixed perfusion defect on SPECT were also
examined by PET. No clinical events or changes in medi-
cation occurred between the studies. Written, informed
consent was obtained, and the study was approved by the
Freiburg Ethical Committee and carried out in accordance
with the Helsinki II Declaration.
Mapping procedure. The three-dimensional navigation-
technology (Biosense Webster) mapping procedure was
described in detail previously (9–14).
Briefly, under fluoroscopic guidance, the mapping cath-
eter was introduced from the right femoral artery and
advanced across the aortic valve into the LV. Three initial
mapping points—the apex, inflow tract, and outflow tract—
were acquired to generate the initial three-dimensional
image. The remaining points (100 on average) were ac-
quired without fluoroscopy. To verify the stability of the
catheter tip with regard to the endocardium, four parame-
ters—location stability, local activation time stability, cycle
length stability, and loop stability—were calculated at each
site. The average mapping time was 49  14 min, and the
average fluoroscopy time was 185  26 s. The mapping
procedure was followed by an automatic filtering process
eliminating points that did not meet the aforementioned
quality parameters as well as points not representing the LV
endocardial surface (i.e., inner points). Only maps with at
least 40 contact points and a reconstruction volume 50 ml
were included in the analysis. Segments with less than three
acquired points were excluded and regarded as empty.
Electrical data. The local unipolar voltage (UV) and bipo-
lar voltage electrograms from the 2-mm tip electrode and a
closely spaced (0.5 mm) 1-mm ring electrode were recorded
at each point. The electrical information was presented as
peak-to-peak amplitude UV maps in a color-coded fashion.
In addition, a quantitative description of the unipolar
QRS complex fragmentation was similarly presented. The
fragmentation index (FI) is independent of the signal’s
amplitude; it is merely dependent on the number and
relative amplitude of the fragments. For an unfragmented
signal, FI  1, whereas an index 1 represents a frag-
mented signal. The algorithm is fully described in the
Appendix.
Mechanical data. Regional contractility was assessed by
calculating the linear local shortening (LLS). This function
has been previously described and validated: briefly, the
algorithm calculates the fractional shortening of the regional
endocardial surface at end systole (11,14).
Segmental analysis. For an analysis comparing NOGA
with the other three-dimensional techniques, the NOGA
endocardial surface was divided into nine segments, and the
data were presented in a regional map (bull’s-eye projec-
tion). The long axis was defined as the line connecting the
apex and the automatically calculated center of the ellipsoid
that envelops the reconstructed LV. The length of the
ventricular long axis was divided into three segments: apex
(20%), mid-ventricle (40%), and base (40%). The mid-
ventricle and base circumference were further divided into
four regions: anterior (80°), septal (120°), inferior/posterior
(80°), and lateral (80°) (Fig. 1).
Echocardiography. Regional contractility was assessed by
echocardiography (Hewlett Packard model 2500) using
standard views and divisions according to the guidelines of
the American Society of Echocardiography. For comparison
with NOGA LV maps, two experienced independent car-
diologists who were blinded to the NOGA and nuclear
imaging results reviewed the echocardiographic results and
applied an additional nine-segment scoring system. Seg-
mental contractility was assessed using a semiquantitative
scoring system (1  normal; 2  hypokinetic; 3  akinetic;
4  dyskinetic) and was compared with the LLS results.
Myocardial SPECT. The SPECT studies were performed
customarily (Sophycamera DS 7, Sopha Medical Vision),
using optimized imaging, acquisition, and processing pro-
tocols according to the imaging guidelines of the American
Society of Nuclear Cardiology, with 99mTc tetrofosmin
(Myoview) (15–17). The tracer (500 to 600 MBq) was
injected intravenously at peak stress. In patients who were
not able to cycle, 0.56 mg/kg of dipyridamole was admin-
istered intravenously. The examination at rest was per-
formed on the following day using 500 to 600 MBq of
99mTc tetrofosmin.
A semiquantitative analysis was performed by two expe-
rienced readers who were blinded to the NOGA and
echocardiographic results. The results were transcribed into
a nine-segment bull’s-eye projection using the following
scoring: 1  normal; 2  perfusion deficit; 3  perfusion
defect; a  reversible; b  partially reversible; c  fixed.
Positron emission tomography. Thirty-one patients with
fixed SPECT perfusion defects underwent a PET study
(UGM, PENN-PET). After overnight fasting, the patients
received an insulin and glucose infusion. Thirty minutes
later, FDG was administered. Positioning of the heart was
assessed by a 12-min transmission scan. Image acquisition
Abbreviations and Acronyms
FDG  18-fluoro-2-deoxy-D-glucose
FI  fragmentation index
LLS  linear local shortening
LV  left ventricle, left ventricular
PET  positron emission tomography
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was delayed for 30 min after the administration of FDG
(250 MBq) to allow transportation of the tracer into the
myocardium and phosphorylation in the cytosol. Then, a
20-min static emission scan and an iterative reconstruction
were performed. The segment with the highest uptake of
99mTc tetrofosmin was regarded as having 100% FDG
uptake. The results were transcribed into a nine-segment
bull’s-eye projection using the following scoring: 1 
normal; 2  limited uptake; 3  no uptake.
Statistical analysis. The statistical analysis was based on a
logistic regression model. As data derived from the com-
parative techniques were available at the segmental level (9
segments per patient), the NOGA parameters were aver-
aged over segments. The ventricular ellipsoid was delineated
by a mesh or grid composed of rectangles (Fig. 2). The net
1,000 grid points per LV map produced by this smooth
reconstruction algorithm was used to compute mean seg-
mental values and the standard deviation of the values of
Figure 1. A zone map demonstrating the transcription of the three-dimensional NOGA map (right anterior oblique view) into a regional bull’s-eye
projection. Each of the nine segments is colored differently (i.e., the apical zone is red). A  anterior; L  lateral; P  posterior; S  septal.
Figure 2. A grid composed of rectangles. After an initial flexible distortion, the model was matched to the sampled points and final smoothing was obtained
by applying a surface convolution and matching a grid node for each sample and moving that node to the sample location. Each grid point then received
a value proportional to its distance from the neighboring points and their values, using color interpolation and smoothing.
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NOGA functions (mean  SD). The segments were
arranged into different groups according to the parameters
of SPECT, PET, and echocardiography. Groups were
compared using the nonparametric test of Kruskal and
Wallis.
Analysis was performed by using the customary SAS/
STAT software, version 7.0 (SAS Institute, Cary, North
Carolina). To perform the logistic regression, the viability
status of the myocardium, as defined by nuclear imaging
(SPECT and PET) and echocardiography, was defined as a
“binary response” (response variables: viable or non-viable).
The parameters of the electromechanical mapping (UV,
LLS, and FI) were used as dependent (explanatory) vari-
ables. On the basis of estimated logistic regression models,
both sensitivity and specificity values were calculated.
Receiver-operating characteristic curve analysis allowed the
evaluation of trade-offs between sensitivity and specificity
associated with different values of the test result. The
thresholds for the various combinations of sensitivity and
specificity were thus computed.
As the main goal was to try to establish universal,
preferably patient-independent, thresholds, inter-patient as
well as intra-patient effects were not introduced into the
statistical model. Inclusion of these effects would have
resulted in an undesired marked reduction of the model’s
quality and validity.
RESULTS
Comparison between NOGA and echocardiography. Of
459 segments (9 segments per patient), 10 had no NOGA
points and an additional 13 could not be interpreted by
echocardiography. Hence, 436 segments were available for
comparison: 246 were normal, 73 were hypokinetic, 81 were
akinetic, and 36 were defined as dyskinetic by echocardiog-
raphy.
Comparative regional contractility assessment. Conser-
vative scoring (4 scores: normal, hypokinetic, akinetic, and
dyskinetic) was initially evaluated. The average LLS of the
normal segments was 9.2  5.1%, which decreased to 6.6 
5.0% and 4.1  5.2% in hypokinetic and akinetic segments,
respectively. The median LLS of the dyskinetic segments
was 3.7  4.4%, which was not significantly lower than that
of the akinetic segments. The LLS could therefore readily
differentiate between normally contracting segments and
segments with either akinesia or dyskinesia by echocardiog-
raphy (p  0.0001) (Fig. 3).
When additional intermediate scores of contractility were
introduced (7 scores: normal, mildly hypokinetic, hypoki-
netic, mildly akinetic, akinetic, mildly dyskinetic, dyskinet-
ic), the LLS function could significantly differentiate even
between normal or mildly hypokinetic segments and truly
hypokinetic segments (9.2  5.0% and 6.2  5.0%, respec-
tively). The rest of the poorly contracting segments had a
median LLS of 3.9  5.0%.
A LLS threshold of 4% identified significant regional
contractility disturbances of akinetic or dyskinetic segments,
with a specificity of 85%. A LLS threshold of 9% defined a
normally contracting segment, with a sensitivity of 90%.
Correlation between electrical activity and regional con-
tractility. The average UV significantly decreased from
12.2  5.2 mV in normal segments to 8.3  3.9 and 8.0 
3.7 mV in hypokinetic and akinetic segments, respectively.
Dyskinetic segments had the lowest median UV (6.7  2.5
mV). The FI was almost the same in normal and hypoki-
netic segments (1.15  0.18 and 1.16  0.19, respectively)
but increased significantly to 1.26  0.25 and 1.25  0.25
in akinetic and dyskinetic segments, respectively (Fig. 3).
Comparison between NOGA and nuclear imaging. COR-
RELATION BETWEEN ELECTROMECHANICAL ASSESSMENT
AND SPECT PERFUSION IMAGING. For the comparison be-
tween NOGA and SPECT, 406 segments were available.
Of these, 332 segments were normally perfused at rest (282
were normal at both rest and stress and 50 segments had
reversible deficits or defects), and 74 had fixed perfusion
defects.
Both electrical and mechanical NOGA parameters were
highly correlated with SPECT scores. The highest UV
(11.2  5.0 mV) and LLS (8.2  5.0%) characterized
normally perfused segments. Reversible segments were not
significantly different at UV and LLS values of 11.7  4.7
mV and 7.6  7.3%, respectively. Fixed perfusion defects
were clearly distinguished by low values of 6.3  3.0 mV
Figure 3. Correlation between NOGA parameters and echocardiography
(echo). 1  normokinesia; 2  hypokinesia; 3  akinesia; 4  dyskinesia.
Data are expressed as the mean value  SD. FI  fragmentation index;
LLS  linear local shortening; UV  unipolar voltage.
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and 3.5  4.0%, respectively, and were significantly different
from both normal and reversible segments (p 0.001) (Fig. 4).
A high FI (1.28  0.23) was characteristic of fixed
perfusion defects and was significantly higher (p  0.001)
than that of normal and reversible segments (1.15  0.18
and 1.19  0.24, respectively) (Fig. 4).
The overall concordance between UV and SPECT was
0.81. However, when the calculation was carried out sepa-
rately for the apex plus mid-ventricle and for the base, the
concordances were 0.83 and 0.9, respectively.
A threshold of UV of 6 mV (Fig. 5), LLS of 4%, or FI
1.5 each identified a fixed perfusion defect, with a speci-
ficity of 90%. A threshold of UV of 10 mV (Fig. 5), LLS of
9%, or FI 1.1 defined a normally perfused segment, with
a sensitivity of 90%.
CORRELATION BETWEEN NOGA AND FDG-PET IMAG-
ING. The PET results of 66 segments with a fixed perfusion
defect were available for comparative analysis with NOGA
results. Of these, 47 had normal (n  28) or limited (n 
19) FDG uptake, indicative of viability, whereas 19 had no
uptake, indicating non-viable scar tissue. Tissue with pre-
served glucose metabolism had a significantly higher UV
(7.25  2.7 and 6.47  2.6 mV for normal and limited
uptake, respectively), as compared with scar tissue (5.0 
3.1 mV, p  0.029). As expected, all fixed perfusion
segments did not differ significantly in their LLS values (3.1
 4.9%, 4.3  4.0%, and 4.3  4.5% for normal, limited,
and no uptake, respectively).
When applying the aforementioned thresholds to define
segments with NOGA parameters indicating fixed defects,
46 segments with UV 6 mV and FI 1.1 had available
PET results. Of these, 34 had normal (n  25) or limited (n
 9) uptake and 12 were non-viable. The UV was signifi-
cantly higher in the viable segments (4.5  0.9 mV) than in
the non-viable segments (3.5  1.0 mV, p  0.0088). A
high FI was similarly characteristic of non-viable segments
Figure 4. Correlation between NOGA parameters and single-photon
emission computed tomography (SPECT) perfusion results. Data are
expressed as the mean value  SD. FI  fragmentation index; LLS 
linear local shortening; UV  unipolar voltage.
Figure 5. Analysis of fixed perfusion defects by positron emission tomography (PET). A desired specificity of 90% defines a lower threshold of 4.5 mV for
PET and 6 mV for single-photon emission computed tomography (SPECT). Thus, the unipolar voltage can differentiate between viable and non-viable
fixed perfusion defects.
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(1.37  0.23 and 1.47  0.3 in viable and non-viable
segments, respectively).
A threshold of UV of 4.5 mV (Fig. 5, 6) and FI 1.5
both identified non-viable tissue, with a specificity of 90%
and a sensitivity of 65%. To identify scar tissue with a high
sensitivity (90%) and to exclude scar tissue with a high
specificity (90%) in areas with a fixed perfusion defect
during SPECT, there may be a gray zone of the UV
between 4.5 and 10 mV, which can make individual
interpretation difficult.
CORRELATION OF NOGA PARAMETERS WITH SIZE OF IN-
FARCTED AREA. Eighteen patients had no fixed defect; 24
had between one and four fixed defects; and seven patients
had up to seven segments with a perfusion defect.
The entire ventricle’s mean UV highly correlated with the
size of the fixed perfusion defect (p  0.0001). The mean
UV decreased from 12.9 mV in patients who had no fixed
defect to 5.9 mV in patients with fixed defects in seven
segments. The entire ventricle’s mean LLS decreased sim-
ilarly from 9% to 3% (p  0.001).
Although the mean UV in the normally perfused terri-
tories decreased accordingly (from 12.9 to 5.5 mV), the UV
within the pathologic zones varied less and was relatively
stable (8.7 to 5 mV; mean 6.3 mV). The LLS in the
pathologic zones, however, decreased according to the
extent of the fixed defect (from 7.6% in ventricles with a
single-segment fixed defect to 2.5% in ventricles with
perfusion defects in 7 segments).
DISCUSSION
Hypothesis. The results of this study confirm the hypoth-
esis that electromechanical assessment in ischemic cardio-
myopathy can differentiate viable from scarred myocardium.
Figure 6. A NOGA unipolar voltage (UV) map from a 69-year-old man with an inferior infarction six years ago and an anteroseptal infarction five years
ago. The single-photon emission computed tomography (SPECT) images reveal an anteroseptal perfusion defect; the positron emission tomography (PET)
polar map shows normal glucose uptake (blue) anteriorly but no glucose uptake (orange) apicoseptally. Viability assessment with the NOGA system
(anteroseptal view at a slight craniocaudal angle on the UV map) provided the following information: the territory of the fixed perfusion defect is precisely
depicted by voltage values 6 mV. The truly non-viable myocardium, as demonstrated by PET, is characterized by voltage values 4.5 mV; the green zone
(4.5–6.0 mV) indicates viable myocardium that may benefit from revascularization.
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Our study focuses on the relationship between electrome-
chanical mapping and combined perfusion and metabolism
imaging. Unipolar voltage does not only differentiate nor-
mally perfused myocardium from fixed perfusion defects,
but it also identifies non-viable zones within the perfusion
defects, in accordance with the findings of PET glucose
utilization. The “hybrid” imaging approach using 99mTc
tetrofosmin SPECT and FDG-PET has been validated
with regard to the determination of myocardial viability and
prediction of functional outcome (18). Only patients with a
mismatch between SPECT (indicating a perfusion defect)
and PET (indicating viability) demonstrated an improved
regional wall motion and a significant reduction of cardiac
events after revascularization. Thus, electromechanical
mapping may be helpful in identifying patients who benefit
most from revascularization. However, this study had not
been designed to answer that question.
Reversible ischemia. The UV of normally perfused seg-
ments and segments with reversible ischemia was identical.
This indicates that areas with reversible ischemia cannot be
identified by peak-to-peak UV amplitude measurements,
which is not surprising, because NOGA electromechanical
mapping was performed only at rest. The inability to
differentiate normal perfusion from reversible ischemia is
further supported by identical LLS values in both normally
perfused segments and segments with reversible ischemia.
These observations are in contrast to the findings of
Kornowski et al. (14), who compared the NOGA electro-
mechanical mapping function only with perfusion imaging
in 18 patients. In this study, there was a significant
difference in the UV of normally perfused segments and
reversible defects, which showed reduced perfusion only
during stress but normal perfusion at rest. Electromechan-
ical mapping under some form of stress (i.e., dobutamine,
dipyridamole, or even handgrip exercise), as well as a more
sophisticated assessment of local electrical activity, could
shed more light on this unsolved issue.
Kornowski et al. (14) reported a mild reduction in
endocardial voltage potentials and LLS in segments with
reversible perfusion defects, as well as a profound electro-
mechanical impairment in segments with fixed defects.
Average values. In our larger study, the average UV in all
three SPECT perfusion categories (normal, reversible, and
fixed perfusion defects) was lower than that in Kornowski’s
study (14). Because we have shown that there is an inverse
relationship between the size of the perfusion defect and the
UV in normally perfused myocardium, we assume that our
patients had a higher incidence of large defects. In fact, in
Kornowski’s study, only patients with an ejection fraction
40% were included. In contrast, in our study, there was no
limitation regarding the ejection fraction.
Study limitations. The results of electromechanical map-
ping, nuclear perfusion and metabolic imaging, and echo-
cardiography have been transcribed into a nine-segment
bull’s-eye projection. For each patient, four nine-segment
models were generated for comparison. The main disadvan-
tage of this segmental approach is a possible malalignment
or “segmental shift” when comparing it with defined seg-
ments of other modalities. In addition, two-dimensional
echocardiographic interpretation of regional wall motion
abnormalities is critically dependent on the reviewer’s ability
to distinguish between segmental myocardial motion and
that motion generated by the translational and rotational
movement of the heart. Wall thickening is an important
parameter in analyzing myocardial contractility by echocar-
diography. This parameter was not taken into account by
the LLS function. As LLS describes the movement of a
point on the endocardial surface, it does not exactly reflect
contractility and cannot distinguish between active and
passive movement.
The difference between the electrical activity measured in
normally perfused regions and that in fixed perfusion defects
decreases as the size of the defect increases. As a conse-
quence, a “smearing effect” might occur in LVs with large
perfusion defects. This makes it more difficult to correctly
determine the accurate borders of the defect. In addition,
the UV within the perfusion defect is lower in extended
than in small defects. This could lead to an underestimation
of viability when a fixed threshold is used.
This study describes the correlation between electrome-
chanical mapping, myocardial SPECT, and PET. Although
the predictive value of combined perfusion and metabolism
imaging for functional recovery has been proven in many
studies, a combined NOGA and angiographic follow-up
after successful revascularization is needed to further con-
firm the correlation between electromechanical parameters
and myocardial recovery.
Conclusions. The NOGA endocardial electromechanical
mapping system is a suitable tool for on-line viability
assessment. Its electromechanical parameters show good
concordance with the combined findings of nuclear perfu-
sion and metabolic imaging. A single diagnostic catheter-
ization procedure consisting of routine coronary angiogra-
phy followed immediately by NOGA mapping allows the
assessment of coronary morphology, LV function, and
myocardial viability in the same session. Patients with
reversible myocardial dysfunction due to hibernation could
be revascularized in the same session. However, this issue
needs further investigation.
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APPENDIX
Algorithm for calculating FI. First, the time boundaries
b1, b2 of a given unipolar intracardiac QRS V(t) were
defined. Then, the QRS complexes were isolated and the
baseline drift removed.
S(t)  V(b1) t 
V(b2) V(b1)
b2  b1
, t0,1 [1]
where b1 and b2 are time moments. For discrete time, it will
be translated into
S(i)  V(b1  i) i 
V(b2) V(b1)
b2  b1
, i  0K b2  b1 [2]
where I, b1, and b2 are time indexes.
The absolute values of the isolated QRS complex deriv-
atives were computed as:
D(t)  dS(t)dt  [3]
or, in discrete form, as:
D(i)  S(i 1) S(i) [4]
The integral curve of the absolute derivative curve was
computed as:
R(t)  
0
t
D	d [5]
or, in the discrete form, as:
R(k)  
i0
ik
D(i) [6]
The final value R(b2) was used to compute the FI as:
F  0.5
R(b2)
max(S) min(S)
[7]
Hence, the FI is independent of the signal’s amplitude and
is merely dependent on the number and relative amplitude
of the fragments. The minimal possible value for F is 1. For
two equal fragments, the value is 2, etc.
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